This article may be written from a
fan's point of view, rather than a
neutral point of view. (November 2021) |
Type | Funding agency |
---|---|
Headquarters | Paris, France |
Location | |
President | André Loesekrug-Pietri |
Vice-President | Antoine Petit |
Website | https://www.jedi.foundation |
The Joint European Disruptive Initiative (JEDI) is a European funding agency aiming at promoting disruptive technologies. Inspired by the US DARPA, [1] it funds innovation in different "missions" (environment and energy, healthcare, education, digital, space, and oceans), [2] with the goal of bringing " Europe in a leadership position in breakthrough technologies". [3] It organizes scientific competitions focused on disruptive technologies. [4] In June 2020, the Joint European Disruptive Initiative was present in 25 countries, with 3.700 persons involved. [5]
The Joint European Disruptive Initiative launched its first "Darpa-type GrandChallenge" [6] on Covid-19 on May 5, 2020. [7] The competition consisted in screening "billions of molecules with blocking interactions on SARS-CoV-2" to develop a drug against the coronavirus — with each participant having to use at least three different calculation methods for the simulations. [8] The foundation claims to have had approximately 54 billions of molecules screened [9] and 878 of them being synthesized. A paper published in Nature showed that the protein PDB 6W9C was one of the most used in silico drug design against Covid-19. [10]
This article may be written from a
fan's point of view, rather than a
neutral point of view. (November 2021) |
Type | Funding agency |
---|---|
Headquarters | Paris, France |
Location | |
President | André Loesekrug-Pietri |
Vice-President | Antoine Petit |
Website | https://www.jedi.foundation |
The Joint European Disruptive Initiative (JEDI) is a European funding agency aiming at promoting disruptive technologies. Inspired by the US DARPA, [1] it funds innovation in different "missions" (environment and energy, healthcare, education, digital, space, and oceans), [2] with the goal of bringing " Europe in a leadership position in breakthrough technologies". [3] It organizes scientific competitions focused on disruptive technologies. [4] In June 2020, the Joint European Disruptive Initiative was present in 25 countries, with 3.700 persons involved. [5]
The Joint European Disruptive Initiative launched its first "Darpa-type GrandChallenge" [6] on Covid-19 on May 5, 2020. [7] The competition consisted in screening "billions of molecules with blocking interactions on SARS-CoV-2" to develop a drug against the coronavirus — with each participant having to use at least three different calculation methods for the simulations. [8] The foundation claims to have had approximately 54 billions of molecules screened [9] and 878 of them being synthesized. A paper published in Nature showed that the protein PDB 6W9C was one of the most used in silico drug design against Covid-19. [10]